Research Article
Breast Cancer Profile among Patients with a History of Chemoprevention
Table 2
Chemoprevention summary.
| | Variables | Primary chemoprevention (, 13%) | % | Secondary chemoprevention (, 87%) | % |
| | Chemoprevention type | | Tamoxifen | 7 | 39 | 82 | 70 | | Raloxifene | 10 | 56 | 6 | 5 | | AI | 1 | 5 | 29 | 25 | | Chemoprevention duration | | <5 years | 11 | 61 | 32 | 27 | | ≥5 years | 7 | 39 | 85 | 73 | | Chemoprevention timing | | Current | 9 | 50 | 28 | 24 | | Previous | 9 | 50 | 89 | 76 |
|
|